Search

everythinglearnresearchcommunity

for

Search:↓

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Oral contraceptives and antiandrogens are effective for treating hirsutism, with antiandrogens being the most effective.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The document concludes that electrolysis and thermolysis can permanently remove hair but calls for better regulation to ensure safety, and notes a possibility of hair regrowth and rare complications.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Hidradenitis suppurativa improves with antiandrogen therapy.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Spironolactone plus finasteride reduces hirsutism more effectively.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.